These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33988887)

  • 1. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial.
    Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
    Arrowitz C; Schoelermann AM; Mann T; Jiang LI; Weber T; Kolbe L
    J Invest Dermatol; 2019 Aug; 139(8):1691-1698.e6. PubMed ID: 30825454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
    Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
    Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial.
    de Amorim RP; Barbosa MMC; Cassiano DP; Esposito ACC; Dias MO; de Abreu AFT; Bagatin E; Miot HA
    Int J Dermatol; 2024 Sep; 63(9):1221-1226. PubMed ID: 38411257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
    Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
    Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiamidol
    Roggenkamp D; Sammain A; Fürstenau M; Kausch M; Passeron T; Kolbe L
    J Dermatol; 2021 Dec; 48(12):1871-1876. PubMed ID: 34676600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial.
    Bertold C; Fontas E; Singh T; Gastaut N; Ruitort S; Wehrlen Pugliese S; Passeron T
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2601-2607. PubMed ID: 37620285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of 0.15% isobutylamido thiazolyl resorcinol combined with hyaluronic acid vs 0.15% isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator-blind trial.
    Disphanurat W; Srisantithum B
    J Cosmet Dermatol; 2021 Nov; 20(11):3563-3572. PubMed ID: 33638926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
    Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
    J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
    Sepaskhah M; Karimi F; Bagheri Z; Kasraee B
    J Cosmet Dermatol; 2022 Jul; 21(7):2871-2878. PubMed ID: 35510765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
    Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
    J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas.
    Wattanakrai P; Nimmannitya K
    J Drugs Dermatol; 2022 Dec; 21(12):1304-1310. PubMed ID: 36468967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
    Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
    Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
    El-Husseiny R; Rakha N; Sallam M
    Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.